Recommendations touch on patient care and infection control.
In an effort to help radiologists make the safest, most informed decisions during the COVID-19 outbreak, the American College of Radiology (ACR) published guidance and resources Tuesday that can help providers offer the best patient care possible during the pandemic.
The ACR stressed the resources are not intended to be comprehensive medical guidelines.
As information about COVID-19 and its spread continues to emerge, radiologists are urged to operate under the following recommendations.
Reschedule Non-Urgent Care
In compliance with the Centers for Disease Control and Prevention (CDC) guidance, the ACR supports rescheduling all non-urgent outpatient visits. This includes:
Work with referring physicians to review and reschedule exams.
Breast Imaging
To reduce the risk of transmission in breast imaging facilities, the ACR stressed that providers should remember these tactics:
CT and X-ray for Suspected Cases
Don’t use CT as a first-line COVID19 diagnostic or screening tool, ACR officials said, following CDC guidance.
Instead, viral testing is required even if CT or X-ray scan reveal findings that are suggestive of COVID19.
Controlling On-Site Infection
To help control the infection risk, the ACR also provided these resources:
From Journal of American College of Radiology, Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know
From the CDC, infection prevention guidance for healthcare professionals
From Radiology, best practices from industry experts
In addition to these resources, ACR officials said the organization with publish up-to-date information as it is made available.
“The ACR will keep members informed regarding future relevant actions that the medical and radiological communities may take that could help protect patients and providers from the coronavirus,” officials said in the statement.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.